Navigation Links
New Pneumococcal Vaccine Approach Successful in Early Tests
Date:2/16/2011

en's also is the primary pediatric teaching affiliate of Harvard Medical School. For more information about research and clinical innovation at Boston Children's visit: Vector Blog.

About GenoceaGenocea Biosciences is a vaccine discovery and development company targeting major infectious diseases with high unmet medical needs, for which T cell responses help confer protection. The company's transformational discovery platform mines the natural immune response across diverse human populations in a way that radically reduces the risk, cost and time associated with antigen discovery. Genocea is currently developing vaccines for herpes simplex-2 (therapeutic and prophylactic), a sexually transmitted disease affecting roughly 15 percent of the U.S. population; Chlamydia trachomatis, a sexually transmitted disease agent causing an estimated 90 million cases worldwide; Streptococcus pneumoniae, the leading killer of children under the age of 5 worldwide; and Plasmodium falciparum (malaria), of which there are more than 100 million cases globally. Visit www.genocea.com for more information.

About PATHPATH is an international nonprofit organization that creates sustainable, culturally relevant solutions, enabling communities worldwide to break longstanding cycles of poor health. By collaborating with diverse public- and private-sector partners, PATH helps provide appropriate health technologies and vital strategies that change the way people think and act. PATH's work improves global health and well-being. For more information, please visit www.path.org.CONTACT: Colleen ConnollyChildren's Hospital Boston617-919-3110colleen.connolly@childrens.harvard.edu
'/>"/>

SOURCE Children's Hospital Boston
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. New Phase 3 Data Continue to Indicate that Wyeths Investigational 13-valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease
2. Cyprus and Ireland Add Wyeths 7-Valent Pneumococcal Conjugate Vaccine (PCV7) to Their National Immunisation Schedules
3. Reportlinker Adds Vaccine Technologies and Global Markets
4. Vaccinex, Inc. Initiates Clinical Trial of Novel Therapeutic Antibody in Cancer Patients With Advanced Solid Tumors
5. NOVAVAX and University of Massachusetts Medical School Publish Preclinical Safety and Efficacy Study of a Respiratory Syncytial Virus (RSV) Virus-like Particle (VLP) Vaccine Candidate
6. Vaccinex, Inc. Awarded Three Qualifying Therapeutic Discovery Project (QTDP) Grants Under the Patient Protection and Affordable Care Act of 2010 (PPACA)
7. Medicago Receives Regulatory Approval and Commences Phase II Clinical Testing of its Avian Influenza Vaccine
8. Paragon Bioservices Awarded $4.99 Million U.S. Army Contract to Assist with Ebola Vaccine Development
9. Reportlinker Adds Triple Analysis: Lymphoma, Cancer Vaccines and Antibodies
10. Medicago holds official groundbreaking ceremony for its U.S. commercial grade vaccine facility
11. Circassia Initiates Phase II Trials of Novel Grass and Ragweed Allergy Therapies and Advances Phase III Plans for cat Allergy T-Cell Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 23, 2013  BioScrip, Inc. (NASDAQ: BIOS ... the Jefferies 2013 Global Healthcare Conference to be held ... Richard Smith , President ... , Chief Financial Officer, will present on Monday, ... About BioScrip BioScrip, Inc. provides ...
(Date:5/23/2013)... 23, 2013 Graphite Metallizing Corporation ... bushings mounted in stainless steel pillow blocks. This ... GRAPHALLOY with the application and installation versatility of ... Blocks work exceptionally well when submerged in ... liquids such as acids, alkalies, hydrocarbons, black liquor, ...
(Date:5/23/2013)... 23, 2013 PuraMed BioScience ® , ... of over-the-counter (OTC) medicinal and healthcare products, announced ... the company based on low market capitalization valuation. ... All Natural Product to Treat Migraine Headaches ... Prescription Competitor , Currently Available Nationwide at ...
(Date:5/23/2013)... 23, 2013 The maker community is ... of inventions. They focus on learning practical skills while ... gravitate toward bringing their ideas to life via crowdfunding. ... works on making projects using biology. Glowing Plant has ... to make them glow with bioluminescence genes, and has ...
Breaking Biology Technology:Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 2Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 3PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home 2
... , WASHINGTON, Sept. 15 BIO Ventures for Global ... chairman of the global health non-profit,s Board of Directors. Feldbaum ... in 2004. , , "I am ... Moree and our board. Up to now, biotech innovation has ...
... , , , ... strain GanedenBC30(R) , today announced the launch of the ... is the latest in a number of innovative probiotic-enhanced products introduced by ... The recent popularity of thin strips as a supplement delivery system led ...
... , , SEATTLE, Sept. ... an in vitro assay service package that helps predict the ... clinical hematotoxicity (myelotoxicity or neutropenia). This assay system is ... novel therapeutic TKIs gain insight into the likelihood and degree ...
Cached Biology Technology:BVGH Announces New Board Chair 2Ganeden Biotech Introduces the First Probiotic Thin Strip 2Ganeden Biotech Introduces the First Probiotic Thin Strip 3ReachBio Launches HemoRANK-TKI Service Package for Predicting Myelotoxicity of New Tyrosine Kinase Inhibitors 2ReachBio Launches HemoRANK-TKI Service Package for Predicting Myelotoxicity of New Tyrosine Kinase Inhibitors 3
(Date:5/24/2013)... of the world,s largest and fastest growing open-access publishers, ... Frontiers in Physics . , A broad scope journal ... provide an open-science and interactive web platform for the ... articles. , Frontiers, real-time and interactive peer-review enables ... article types. With an average of three months from ...
(Date:5/24/2013)... against Alzheimer,s disease, scientists have focused among other factors ... After all, it is the accumulation of A-beta that causes ... point for the formation of A-beta is APP. Alessia Soldano ... the function of APPL the fruit-fly version of APP ... Alessia Soldano (VIB/KU Leuven): "We have discovered that APPL ensures ...
(Date:5/23/2013)... more than 284 million tons of cargo, transit the Panama ... fees for the Panama Canal Authority. Each time a ship ... used from Gatun Lake, which is also a source of ... , However, the advent of very large "super" cargo ... sea, has demanded change. The Panama Canal is being expanded ...
Breaking Biology News(10 mins):Frontiers launches new open-access journal in physics 2Frontiers launches new open-access journal in physics 3A new strategy required in the search for Alzheimer's drugs? 2Reforestation study shows trade-offs between water, carbon and timber 2Reforestation study shows trade-offs between water, carbon and timber 3
... graduate from college, the U.S. corn belt could be forced ... waves brought on by rising global temperatures. If farmers don,t ... lead to bigger swings in corn prices "price volatility" ... the price livestock farmers and ethanol producers pay for corn. ...
... and taxation on products containing salt in 19 developing countries ... disease (CVD) by 2-3 per cent in these countries. The ... are the first findings from a new report from Harvard ... The study set out to assess the cost-effectiveness of two ...
... Public health was not part of the initial discussions about ... information about any health impacts of the technologies and process. ... will use hydraulic fracturing, or "fracking," as a case example ... and explore potential health consequences of emerging energy technologies. ...
Cached Biology News:Climate change may create price volatility in the corn market, say Stanford and Purdue researchers 2Tax on salt could reduce cardiovascular disease deaths by 3 percent 2
The BD PhosFlow Fix Buffer I can be used for the simultaneous fixation and permeabilization of cells prior to intracellular staining. Applications: Intracellular Staining (Flow) Storage Temperature:...
Rabbit polyclonal to 3-Ethynylestradiol ( Abpromise for all tested applications). Antigen: Ethynylestradiol conjugated to BSA....
Request Info...
... Large T antigen initiates replication ... replication in the presence of ... product can be used in ... Replication Kit cat. no. 8050. ...
Biology Products: